Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuphoria Therapeutics (NEUP) Treasury Shares (2025)

Historic Treasury Shares for Neuphoria Therapeutics (NEUP) over the last 1 years, with Q3 2025 value amounting to $33915.0.

  • Neuphoria Therapeutics' Treasury Shares changed N/A to $33915.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $33915.0, marking a year-over-year change of. This contributed to the annual value of $33915.0 for FY2025, which is N/A changed from last year.
  • As of Q3 2025, Neuphoria Therapeutics' Treasury Shares stood at $33915.0.
  • Neuphoria Therapeutics' Treasury Shares' 5-year high stood at $33915.0 during Q2 2025, with a 5-year trough of $33915.0 in Q2 2025.